HQY Healthequity PE ratio, current and historical analysis

?
Relative Growth: Rel. Growth: 88
Relative Strength: Rel. Strength: 56
Relative Valuation: Rel. Valuation: 52
Relative Profitability: Rel. Profitability: 94

As of Jul 24, 2026, the Healthequity stock's price-to-earnings ratio is 35.18. This results from the current EPS of $2.69 and stock price of $94.64. The PE ratio has decreased by 15% from the past four quarters average of 41.3.

HQY PE ratio history

How has HQY's PE ratio performed in the past

The PE ratio of Healthequity has averaged 597.92 over the last ten years. The current P/E ratio of 35.18 is 94% lower than the historical average. In the past ten years, HQY's PE ratio peaked in the Jul 2021 quarter at 7,398, when the stock price was $73.98 and the EPS was $0.01. The lowest point was in the Apr 2026 quarter, when it reached 30.49 with a price of $82.03 and an EPS of $2.69.

Today
35.18
Average
597.92
Median
75.81
Minimum
30.49
Maximum
7,398

Healthequity PE ratio by year

Maximum annual increase: 521.82% in 2021

Maximum annual decrease: -65.55% in 2026

Year PE ratio PE change Price EPS
2026 34.27 -65.55% $85.67 $2.5
2025 99.48 -14.45% $110.42 $1.11
2024 116.28 N/A $75.58 $0.65
2023 N/A N/A $60.85 -$0.31
2022 N/A N/A $53.44 -$0.53
2021 696.25 521.82% $83.55 $0.12
2020 111.97 115.53% $66.06 $0.59
2019 51.95 -18.93% $62.34 $1.2
2018 64.08 -37.65% $50.62 $0.79
2017 102.78 38.31% $46.25 $0.45
2016 74.31 39.52% $21.55 $0.29
2015 53.26 N/A $20.77 $0.39
2014 N/A N/A N/A -$1.26
2013 N/A N/A N/A $0.81

Healthequity PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Apr 2026 30.49 -11.03% $82.03 $2.69
Jan 2026 34.27 -19.93% $85.67 $2.5
Oct 2025 42.8 -25.87% $94.58 $2.21
Jul 2025 57.74 -5.7% $97 $1.68
Apr 2025 61.23 -38.45% $85.72 $1.4
Jan 2025 99.48 30.69% $110.42 $1.11
Oct 2024 76.12 18.33% $85.25 $1.12
Jul 2024 64.33 -24.18% $78.48 $1.22
Apr 2024 84.85 -27.03% $78.91 $0.93
Jan 2024 116.28 -44.84% $75.58 $0.65
Oct 2023 210.82 -53.45% $71.68 $0.34
Jul 2023 452.93 N/A $67.94 $0.15
Apr 2023 N/A N/A $53.45 -$0.1
Jan 2023 N/A N/A $60.85 -$0.31
Oct 2022 N/A N/A $77.91 -$0.7

HQY Price vs fair value

How does HQY's price compare to its estimated fair value based on its growth

HQY average PE ratio chart

What is the average PE ratio of HQY for the past years

The current PE ratio of HQY is lower than the 3, 5 and 10-year averages.

3-year avg
110.95
5-year avg
671.49
10-year avg
597.92
15-year avg
N/A

PE comparison

Healthequity's P/E of 35.18 is above the Healthcare sector and the industry average. In comparison with its Healthcare sector average of 25.31, Healthequity's P/E is 39% higher.

HQY PE vs peers

What is HQY's PE ratio compared to its peers

In comparison to its peer UHAL, HQY's PE ratio is lower, but it is higher than EZPW's.

Stock name PE ratio Market cap
EZPW Ezcorp Inc 12.26 $1.82B
HQY Healthequity Inc 35.18 $7.91B
UHAL Amerco 297.63 $14.01B

Frequently asked questions

What is Healthequity's PE ratio?

HQY's price to earnings ratio is 35.18 as of Jul 24, 2026.

What is the 3-year average PE ratio for Healthequity (HQY)?

Over the last 3 years, the average price to earnings ratio for HQY stock is 110.95.

What is the 5-year average PE ratio for Healthequity (HQY)?

Over the last 5 years, the average price to earnings ratio for HQY stock is 671.49.

What is the highest PE ratio for HQY?

In the last ten years, the Jul 2021 quarter recorded the highest quarterly PE ratio at 7,398.

How does the current PE ratio for HQY compare to its historical average?

HQY's price to earnings ratio is currently 94% below its 10-year historical average.

How is HQY's PE ratio calculated (Healthequity PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 24, 2026), Healthequity's stock price is $94.64. The earnings per share for the trailing twelve months (TTM) ending Apr 2026 is $2.69. Therefore, Healthequity's PE ratio for today is 35.18. PE RATIO(35.18) = STOCK PRICE($94.64) / TTM EPS($2.69)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.